TheraRadar

Pharma Intelligence, Simplified

Data updated: Mar 10, 2026

TAZICEF

CEFTAZIDIME
Infectious Disease Approved 1986-03-06
2
Indications
--
Phase 3 Trials
40
Years on Market

Details

Status
Prescription
First Approved
1986-03-06
Routes
INJECTION
Dosage Forms
INJECTABLE

Companies

Active Ingredient: CEFTAZIDIME

TAZICEF Approval History

Loading approval history...

What TAZICEF Treats

6 indications

TAZICEF is approved for 6 conditions since its original approval in 1986. These indications span multiple therapeutic areas including oncology, immunology, and more.

  • Lower Respiratory Tract Infection
  • Pneumonia
  • Skin and Skin-Structure Infection
  • Urinary Tract Infection
  • Bacterial Septicemia
  • Bone and Joint Infection
Source: FDA Label

Drugs Similar to TAZICEF

FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.

CEFUROXIME
CEFUROXIME
5 shared
Hikma
Shared indications:
Lower Respiratory Tract InfectionPneumoniaUrinary Tract Infection +2 more
AZACTAM
AZTREONAM
4 shared
Bristol-Myers Squibb
Shared indications:
Urinary Tract InfectionLower Respiratory Tract InfectionPneumonia +1 more
AZTREONAM
AZTREONAM
4 shared
Pfizer
Shared indications:
Urinary Tract InfectionLower Respiratory Tract InfectionPneumonia +1 more
CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER
CEFOXITIN SODIUM
3 shared
B BRAUN
Shared indications:
Lower Respiratory Tract InfectionPneumoniaUrinary Tract Infection
CEFOXITIN IN PLASTIC CONTAINER
CEFOXITIN SODIUM
3 shared
SAMSON MEDCL
Shared indications:
Lower Respiratory Tract InfectionPneumoniaUrinary Tract Infection
AMOXICILLIN PEDIATRIC
AMOXICILLIN
2 shared
Teva
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
ARIKAYCE KIT
AMIKACIN SULFATE
2 shared
INSMED INC
Shared indications:
Bacterial SepticemiaUrinary Tract Infection
AUGMENTIN '125'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN '250'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN '875'
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
AUGMENTIN XR
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
B BRAUN
Shared indications:
PneumoniaUrinary Tract Infection
CEFEPIME HYDROCHLORIDE
CEFEPIME HYDROCHLORIDE
2 shared
QILU ANTIBIOTICS
Shared indications:
PneumoniaUrinary Tract Infection
CEFEPIME HYDROCHLORIDE IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
SAMSON MEDCL
Shared indications:
PneumoniaUrinary Tract Infection
CEFEPIME IN PLASTIC CONTAINER
CEFEPIME HYDROCHLORIDE
2 shared
Baxter
Shared indications:
PneumoniaUrinary Tract Infection
CEFOTAN
CEFOTETAN DISODIUM
2 shared
PAI HOLDINGS PHARM
Shared indications:
Urinary Tract InfectionLower Respiratory Tract Infection
DIFLUCAN
FLUCONAZOLE
2 shared
Pfizer
Shared indications:
Urinary Tract InfectionPneumonia
LANSOPRAZOLE, AMOXICILLIN AND CLARITHROMYCIN (COPACKAGED)
AMOXICILLIN
2 shared
Novartis
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
LAROTID
AMOXICILLIN
2 shared
US ANTIBIOTICS
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
VOQUEZNA TRIPLE PAK
AMOXICILLIN
2 shared
PHATHOM
Shared indications:
Lower Respiratory Tract InfectionUrinary Tract Infection
๐Ÿ”ฌ

Active Pipeline

Pro

Ongoing clinical trials by development phase

Loading...
โญ

Key Completed Trials

Pro

Completed studies with published results, ranked by significance

Loading...
๐Ÿ“Š

Trial Timeline

Full development history with FDA approval milestones

Loading...
Understanding FDA Approval Types
Count Type What it means
- ORIG Original approval - drug first enters market
- SUPPL - Efficacy New indication (new disease/condition approved)
- SUPPL - Labeling Label text changes (warnings, dosing updates)
- SUPPL - Manufacturing Production changes (new facility)
- SUPPL - Chemistry Formulation changes (new dosage strength)

Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.

TAZICEF FDA Label Details

Pro

Indications & Usage

Tazicef (ceftazidime for injection, USP) is indicated for the treatment of patients with infections caused by susceptible strains of the designated organisms in the following diseases: 1. Lower Respiratory Tract Infections, including pneumonia, caused by Pseudomonas aeruginosa and other Pseudomonas spp.; Haemophilus influenzae , including ampicillin-resistant strains; Klebsiella spp.; Enterobacter spp.; Proteus mirabilis; Escherichia coli; Serratia spp.; Citrobacter spp.; Streptococcus pneumoniae ; and Staphylococcus aureus (methicillin-susceptible strains). 2. Skin and Skin-Structure Infectio...

Want competitive intelligence?

See who's developing similar drugs and track their progress

View Pipeline Dashboard

Data Sources

Data sourced from official FDA and NIH databases. Click links to verify on original sources.